Q3 2013 report roundup -- Gevo, Amyris, and Solazyme disclose financials and make announcements

November 14, 2013 | Analyst Insight

Gevo ended the quarter with $25.7 million in cash and cash equivalents, with a net cash consumption of $14.9 million since June 30, 2013. On the revenue side, $1.1...